Expert Video - Why is diversity important in MDS clinical trials? What benefits do diverse clinical trials provide?
Hematologist and oncologist, Dr. Amy DeZern discusses why diversity is important in MDS clinical trials and what benefits diverse clinical trials provide. She explains that clinical trials should aim to reflect the diversity of the many different individuals that make up a population to better determine whether a clinical trial intervention is helpful to a broad spectrum of people or a specific subset. Since historically, clinical trial participants were less diverse, Dr. DeZern emphasizes the importance that participant enrollment reflect a broader range of considerations such as: disease type, race, ethnicity, healthcare, and economic diversity. This would help ensure that a new treatment is more broadly applicable and available to everyone suffering from MDS.
Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about MDS which will help other patients, caregivers and families.
Animation - Including Everyone in Clinical Trials for MDS
Slide Show - Including Everyone in Clinical Trials for MDS
1.
Why is diversity important in MDS clinical trials? What benefits do diverse clinical trials provide?
2.
Why are some MDS patients not participating in clinical trials? What are the barriers to enrollment?
3.
If I feel uncomfortable during a clinical trial am I obligated to participate?
4.
How can I find an MDS clinical trial that is appropriate for me?
